Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

doi:10.1084/jem.179.2.523

This Article

	Full Text (PDF, 901K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Chen, L.
	Articles by Hellstrom, K. E.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Chen, L.
	Articles by Hellstrom, K. E.

Social Bookmarking

	What's this?

ARTICLES

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

L Chen, P McGowan, S Ashe, J Johnston, Y Li, I Hellstrom and KE Hellstrom
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.

A costimulatory signal through B7 to its counter-receptor CD28 on T cells enhances T cell activation. We have generated recombinant retroviruses containing cDNA for murine B7 and transduced a panel of murine tumor lines with varying immunogenicity to study the effect of B7 costimulation on antitumor immunity. In contrast to the progressive outgrowth of all wild-type (B7-) tumors in unimmunized syngeneic mice, four immunogenic tumors, lymphoma RMA, EL4, mastocytoma P815, and melanoma E6B2, regressed completely when transduced with the B7 gene. In contrast, four nonimmunogenic tumors, sarcomas MCA101, MCA102, and Ag104, and melanoma B16, remained tumorigenic after transduction of the B7 gene. Immunization with B7-transduced immunogenic tumors enhanced protective immunity and increased specific cytotoxic T lymphocyte (CTL) activity against the respective wild-type tumors as compared to immunization with nontransduced or mock-transduced tumors. Moreover, cocultivation of CTL with B7-transduced EL4 cells augmented the specificity of tumor-reactive CTL in long-term cultures. Treatment by injection of B7-transduced tumor cells cured 60% of mice with established wild-type EL4 lymphoma. In contrast, immunization with nonimmunogenic tumors transduced with B7 did not provide protective immunity and did not increase specific CTL activity. Our results show that tumor immunogenicity is critical to the outcome of costimulation of T cell-mediated tumor immunity by B7.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Suzuki, T., Ogawa, S., Tanabe, K., Tahara, H., Abe, R., Kishimoto, H. (2008). Induction of Antitumor Immune Response by Homeostatic Proliferation and CD28 Signaling. J. Immunol. 180: 4596-4605 [Abstract] [Full Text]
Zang, X., Allison, J. P. (2007). The B7 Family and Cancer Therapy: Costimulation and Coinhibition. Clin. Cancer Res. 13: 5271-5279 [Abstract] [Full Text]
Hoshitani, Y., Ishida, H., Otsuki, N., Shirakawa, T., Gotoh, A., Nibu, K.-i. (2007). Induction of Immunological Antitumor Effects by Adenovirus-Mediated Gene Transfer of B7-1 in a Murine Squamous Cell Carcinoma Cell Line. Arch Otolaryngol Head Neck Surg 133: 270-275 [Abstract] [Full Text]
Lee, Y.-S., Kim, J.-H., Choi, K.-J., Choi, I.-K., Kim, H., Cho, S., Cho, B. C., Yun, C.-O. (2006). Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and b7-1 in an immunocompetent murine model.. Clin. Cancer Res. 12: 5859-5868 [Abstract] [Full Text]
Vianello, F., Papeta, N., Chen, T., Kraft, P., White, N., Hart, W. K., Kircher, M. F., Swart, E., Rhee, S., Palu, G., Irimia, D., Toner, M., Weissleder, R., Poznansky, M. C. (2006). Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control.. J. Immunol. 176: 2902-2914 [Abstract] [Full Text]
Tirapu, I., Huarte, E., Guiducci, C., Arina, A., Zaratiegui, M., Murillo, O., Gonzalez, A., Berasain, C., Berraondo, P., Fortes, P., Prieto, J., Colombo, M. P., Chen, L., Melero, I. (2006). Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma. Cancer Res. 66: 2442-2450 [Abstract] [Full Text]
Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S.-D., Dong, H., Chen, L., Ogata, K. (2005). Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia. Clin. Cancer Res. 11: 5708-5717 [Abstract] [Full Text]
Shi, G., Mao, J., Yu, G., Zhang, J., Wu, J. (2005). Tumor Vaccine Based on Cell Surface Expression of DcR3/TR6. J. Immunol. 174: 4727-4735 [Abstract] [Full Text]
Saudemont, A., Jouy, N., Hetuin, D., Quesnel, B. (2005). NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105: 2428-2435 [Abstract] [Full Text]
Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., Tamada, K., Chen, L. (2005). Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity. Cancer Res. 65: 1089-1096 [Abstract] [Full Text]
Luo, L., Chapoval, A. I., Flies, D. B., Zhu, G., Hirano, F., Wang, S., Lau, J. S., Dong, H., Tamada, K., Flies, A. S., Liu, Y., Chen, L. (2004). B7-H3 Enhances Tumor Immunity In Vivo by Costimulating Rapid Clonal Expansion of Antigen-Specific CD8+ Cytolytic T Cells. J. Immunol. 173: 5445-5450 [Abstract] [Full Text]
van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., Altin, J. G. (2004). Targeting Dendritic Cells with Antigen-Containing Liposomes: A Highly Effective Procedure for Induction of Antitumor Immunity and for Tumor Immunotherapy. Cancer Res. 64: 4357-4365 [Abstract] [Full Text]
Friedlander, P. L., Delaune, C. L., Abadie, J. M., Toups, M., LaCour, J., Marrero, L., Zhong, Q., Kolls, J. K. (2003). Efficacy of CD40 Ligand Gene Therapy in Malignant Mesothelioma. Am. J. Respir. Cell Mol. Bio. 29: 321-330 [Abstract] [Full Text]
Lee, K.-M., Bhawan, S., Majima, T., Wei, H., Nishimura, M. I., Yagita, H., Kumar, V. (2003). Cutting Edge: The NK Cell Receptor 2B4 Augments Antigen-Specific T Cell Cytotoxicity Through CD48 Ligation on Neighboring T Cells. J. Immunol. 170: 4881-4885 [Abstract] [Full Text]
Hu, H.-M., Winter, H., Ma, J., Croft, M., Urba, W. J., Fox, B. A. (2002). CD28, TNF Receptor, and IL-12 Are Critical for CD4-Independent Cross-Priming of Therapeutic Antitumor CD8+ T Cells. J. Immunol. 169: 4897-4904 [Abstract] [Full Text]
Ogasawara, K., Yoshinaga, S. K., Lanier, L. L. (2002). Inducible Costimulator Costimulates Cytotoxic Activity and IFN-{gamma} Production in Activated Murine NK Cells. J. Immunol. 169: 3676-3685 [Abstract] [Full Text]
Kass, E. S., Greiner, J. W., Kantor, J. A., Tsang, K. Y., Guadagni, F., Chen, Z., Clark, B., Pascalis, R. D., Schlom, J., Van Waes, C. (2002). Carcinoembryonic Antigen as a Target for Specific Antitumor Immunotherapy of Head and Neck Cancer. Cancer Res. 62: 5049-5057 [Abstract] [Full Text]
Miller, R. E., Jones, J., Le, T., Whitmore, J., Boiani, N., Gliniak, B., Lynch, D. H. (2002). 4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner. J. Immunol. 169: 1792-1800 [Abstract] [Full Text]
Scholler, N., Hayden-Ledbetter, M., Dahlin, A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A. (2002). Cutting Edge: CD83 Regulates the Development of Cellular Immunity. J. Immunol. 168: 2599-2602 [Abstract] [Full Text]
LaBelle, J. L., Hanke, C. A., Blazar, B. R., Truitt, R. L. (2002). Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. Blood 99: 2146-2153 [Abstract] [Full Text]
Mittrucker, H.-W., Kursar, M., Kohler, A., Hurwitz, R., Kaufmann, S. H. E. (2001). Role of CD28 for the Generation and Expansion of Antigen-Specific CD8+ T Lymphocytes During Infection with Listeria monocytogenes. J. Immunol. 167: 5620-5627 [Abstract] [Full Text]
Zheng, G., Chen, A., Sterner, R. E., Zhang, P. J., Pan, T., Kiyatkin, N., Tykocinski, M. L. (2001). Induction of Antitumor Immunity via Intratumoral Tetra-Costimulator Protein Transfer. Cancer Res. 61: 8127-8134 [Abstract] [Full Text]
Bai, X.-F., Bender, J., Liu, J., Zhang, H., Wang, Y., Li, O., Du, P., Zheng, P., Liu, Y. (2001). Local Costimulation Reinvigorates Tumor-Specific Cytolytic T Lymphocytes for Experimental Therapy in Mice with Large Tumor Burdens. J. Immunol. 167: 3936-3943 [Abstract] [Full Text]
Grosenbach, D. W., Barrientos, J. C., Schlom, J., Hodge, J. W. (2001). Synergy of Vaccine Strategies to Amplify Antigen-specific Immune Responses and Antitumor Effects. Cancer Res. 61: 4497-4505 [Abstract] [Full Text]
Tamura, H., Dong, H., Zhu, G., Sica, G. L., Flies, D. B., Tamada, K., Chen, L. (2001). B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97: 1809-1816 [Abstract] [Full Text]
Ohlen, C., Kalos, M., Hong, D. J., Shur, A. C., Greenberg, P. D. (2001). Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8+ T Cells or CTL Immunotherapy of Tumors Expressing the Antigen. J. Immunol. 166: 2863-2870 [Abstract] [Full Text]
Todo, T., Martuza, R. L., Dallman, M. J., Rabkin, S. D. (2001). In Situ Expression of Soluble B7-1 in the Context of Oncolytic Herpes Simplex Virus Induces Potent Antitumor Immunity. Cancer Res. 61: 153-161 [Abstract] [Full Text]
Brawand, P., Lemonnier, F. A., MacDonald, H. R., Cerottini, J.-C., Held, W. (2000). Transgenic Expression of Ly49A on T Cells Impairs a Specific Antitumor Response. J. Immunol. 165: 1871-1876 [Abstract] [Full Text]
Davila, E., Celis, E. (2000). Repeated Administration of Cytosine-Phosphorothiolated Guanine-Containing Oligonucleotides Together with Peptide/Protein Immunization Results in Enhanced CTL Responses with Anti-Tumor Activity. J. Immunol. 165: 539-547 [Abstract] [Full Text]
Chapoval, A. I., Tamada, K., Chen, L. (2000). In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95: 2346-2351 [Abstract] [Full Text]
van Broekhoven, C. L., Parish, C. R., Vassiliou, G., Altin, J. G. (2000). Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development. J. Immunol. 164: 2433-2443 [Abstract] [Full Text]
Weinberg, A. D., Rivera, M.-M., Prell, R., Morris, A., Ramstad, T., Vetto, J. T., Urba, W. J., Alvord, G., Bunce, C., Shields, J. (2000). Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity. J. Immunol. 164: 2160-2169 [Abstract] [Full Text]
Wang, B., Maile, R., Greenwood, R., Collins, E. J., Frelinger, J. A. (2000). Naive CD8+ T Cells Do Not Require Costimulation for Proliferation and Differentiation into Cytotoxic Effector Cells. J. Immunol. 164: 1216-1222 [Abstract] [Full Text]
Hiroishi, K., Tuting, T., Lotze, M. T. (2000). IFN-{alpha}-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs. J. Immunol. 164: 567-572 [Abstract] [Full Text]
Buggins, A.G.S., Lea, N., Gaken, J., Darling, D., Farzaneh, F., Mufti, G.J., Hirst, W.J.R. (1999). Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells. Blood 94: 3479-3490 [Abstract] [Full Text]
Sturmhoefel, K., Lee, K., Gray, G. S., Thomas, J., Zollner, R., O'Toole, M., Swiniarski, H., Dorner, A., Wolf, S. F. (1999). Potent Activity of Soluble B7-IgG Fusion Proteins in Therapy of Established Tumors and as Vaccine Adjuvant. Cancer Res. 59: 4964-4972 [Abstract] [Full Text]
Hodge, J. W., Schlom, J. (1999). Comparative Studies of a Retrovirus versus a Poxvirus Vector in Whole Tumor-Cell Vaccines. Cancer Res. 59: 5106-5111 [Abstract] [Full Text]
de Ines, C., Cochlovius, B., Schmidt, S., Kipriyanov, S., Rode, H.-J., Little, M. (1999). Apoptosis of a Human Melanoma Cell Line Specifically Induced by Membrane-Bound Single-Chain Antibodies. J. Immunol. 163: 3948-3956 [Abstract] [Full Text]
Smythe, J. A., Fink, P. D., Logan, G. J., Lees, J., Rowe, P. B., Alexander, I. E. (1999). Human Fibroblasts Transduced with CD80 or CD86 Efficiently trans-Costimulate CD4+ and CD8+ T Lymphocytes in HLA-Restricted Reactions: Implications for Immune Augmentation Cancer Therapy and Autoimmunity. J. Immunol. 163: 3239-3249 [Abstract] [Full Text]
Zheng, P., Sarma, S., Guo, Y., Liu, Y. (1999). Two Mechanisms for Tumor Evasion of Preexisting Cytotoxic T-Cell Responses: Lessons from Recurrent Tumors. Cancer Res. 59: 3461-3467 [Abstract] [Full Text]
Galea-Lauri, J., Darling, D., Gan, S.-U., Krivochtchapov, L., Kuiper, M., Gaken, J., Souberbielle, B., Farzaneh, F. (1999). Expression of a Variant of CD28 on a Subpopulation of Human NK Cells: Implications for B7-Mediated Stimulation of NK Cells. J. Immunol. 163: 62-70 [Abstract] [Full Text]
Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., Bellone, M. (1999). Immunogenicity of Apoptotic Cells In Vivo: Role of Antigen Load, Antigen-Presenting Cells, and Cytokines. J. Immunol. 163: 130-136 [Abstract] [Full Text]
Soo Hoo, W., Lundeen, K. A., Kohrumel, J. R., Pham, N.-L., Brostoff, S. W., Bartholomew, R. M., Carlo, D. J. (1999). Tumor Cell Surface Expression of Granulocyte-Macrophage Colony-Stimulating Factor Elicits Antitumor Immunity and Protects from Tumor Challenge in the P815 Mouse Mastocytoma Tumor Model. J. Immunol. 162: 7343-7349 [Abstract] [Full Text]
Evans, T.R.J., Kaye, S.B. (1999). Vaccine therapy for cancer�fact or fiction?. QJM 92: 299-307 [Full Text]
Martin, B. K., Frelinger, J. G., Ting, J. P.-Y. (1999). Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth. J. Immunol. 162: 6663-6670 [Abstract] [Full Text]
Biancone, L., Stamenkovic, I., Cantaluppi, V., Boccellino, M., De Martino, A., Bussolino, F., Camussi, G. (1999). Expression of L-Selectin Ligands by Transformed Endothelial Cells Enhances T Cell-Mediated Rejection. J. Immunol. 162: 5263-5269 [Abstract] [Full Text]
Motte, R. N. L., Sharpe, A. H., Bluestone, J. A., Mokyr, M. B. (1999). Host B7-1 and B7-2 Costimulatory Molecules Contribute to the Eradication of B7-1-Transfected P815 Tumor Cells Via a CD8+ T Cell-Dependent Mechanism. J. Immunol. 162: 4817-4823 [Abstract] [Full Text]
Guinn, B.-a., DeBenedette, M. A., Watts, T. H., Berinstein, N. L. (1999). 4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine. J. Immunol. 162: 5003-5010 [Abstract] [Full Text]
Stremmel, C., Greenfield, E.A., Howard, E., Freeman, G.J., Kuchroo, V.K. (1999). B7-2 Expressed on EL4 Lymphoma Suppresses Antitumor Immunity by an Interleukin 4-dependent Mechanism. JEM 189: 919-930 [Abstract] [Full Text]
Tanaka, H., Yoshizawa, H., Yamaguchi, Y., Ito, K., Kagamu, H., Suzuki, E., Gejyo, F., Hamada, H., Arakawa, M. (1999). Successful Adoptive Immunotherapy of Murine Poorly Immunogenic Tumor with Specific Effector Cells Generated from Gene-Modified Tumor-Primed Lymph Node Cells. J. Immunol. 162: 3574-3582 [Abstract] [Full Text]
Shrikant, P., Mescher, M. F. (1999). Control of Syngeneic Tumor Growth by Activation of CD8+ T Cells: Efficacy Is Limited by Migration Away from the Site and Induction of Nonresponsiveness. J. Immunol. 162: 2858-2866 [Abstract] [Full Text]
Foon, K. A., Yannelli, J., Bhattacharya-Chatterjee, M. (1999). Colorectal Cancer as a Model for Immunotherapy. Clin. Cancer Res. 5: 225-236 [Full Text]
Kutubuddin, M., Federoff, H. J., Challita-Eid, P. M., Halterman, M., Day, B., Atkinson, M., Planelles, V., Rosenblatt, J. D. (1999). Eradication of Pre-Established Lymphoma Using Herpes Simplex Virus Amplicon Vectors. Blood 93: 643-654 [Abstract] [Full Text]
La Motte, R. N., Sharpe, A. H., Bluestone, J. A., Mokyr, M. B. (1998). Importance of B7-1-Expressing Host Antigen-Presenting Cells for the Eradication of B7-2 Transfected P815 Tumor Cells. J. Immunol. 161: 6552-6558 [Abstract] [Full Text]
Rivoltini, L., Radrizzani, M., Accornero, P., Squarcina, P., Chiodoni, C., Mazzocchi, A., Castelli, C., Tarsini, P., Viggiano, V., Belli, F., Colombo, M. P., Parmiani, G. (1998). Human Melanoma-Reactive CD4+ and CD8+ CTL Clones Resist Fas Ligand-Induced Apoptosis and Use Fas/Fas Ligand-Independent Mechanisms for Tumor Killing. J. Immunol. 161: 1220-1230 [Abstract] [Full Text]
Wong, L. H., Hatzinisiriou, I., Devenish, R. J., Ralph, S. J. (1998). IFN-{gamma} Priming Up-Regulates IFN-Stimulated Gene Factor 3 (ISGF3) Components, Augmenting Responsiveness of IFN-Resistant Melanoma Cells to Type I IFNs. J. Immunol. 160: 5475-5484 [Abstract] [Full Text]
Kwak, L. W., Pennington, R., Boni, L., Ochoa, A. C., Robb, R. J., Popescu, M. C. (1998). Cutting Edge: Liposomal Formulation of a Self Lymphoma Antigen Induces Potent Protective Antitumor Immunity. J. Immunol. 160: 3637-3641 [Abstract] [Full Text]
Challita-Eid, P. M., Penichet, M. L., Shin, S.-U., Poles, T., Mosammaparast, N., Mahmood, K., Slamon, D. J., Morrison, S. L., Rosenblatt, J. D. (1998). A B7.1-Antibody Fusion Protein Retains Antibody Specificity and Ability to Activate Via the T Cell Costimulatory Pathway. J. Immunol. 160: 3419-3426 [Abstract] [Full Text]
Emtage, P. C. R., Wan, Y., Bramson, J. L., Graham, F. L., Gauldie, J. (1998). A Double Recombinant Adenovirus Expressing the Costimulatory Molecule B7-1 (Murine) and Human IL-2 Induces Complete Tumor Regression in a Murine Breast Adenocarcinoma Model. J. Immunol. 160: 2531-2538 [Abstract] [Full Text]
Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]
Putzer, B. M., Hitt, M., Muller, W. J., Emtage, P., Gauldie, J., Graham, F. L. (1997). Interleukin 12�and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor�regression. Proc. Natl. Acad. Sci. USA 94: 10889-10894 [Abstract] [Full Text]
Dunussi-Joannopoulos, K., Krenger, W., Weinstein, H. J., Ferrara, J. L.M., Croop, J. M. (1997). CD8+ T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment. Blood 89: 2915-2924 [Abstract] [Full Text]
Kundig, T., Bachmann, M., DiPaolo, C, Simard, J., Battegay, M, Lother, H, Gessner, A, Kuhlcke, K, Ohashi, P., Hengartner, H, et, al. (1995). Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343-1347 [Abstract]